Position history for FARALLON CAPITAL MANAGEMENT LLC's holdings in ENANTA PHARMACEUTICALS INC
FARALLON CAPITAL MANAGEMENT LLC holds 2.9M shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $36.3M as of 2026-Q1. The position was increased (+3.6% shares). ENTA represents 0.2% of FARALLON CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$36.3M
Current Shares
2.9M
Total Value Change
+$9.1M
Total Shares Change
+776,862
Other major holders of ENTA: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2.9M |
+3.6% |
| $36.3M |
| 0.2% |
| $14.72 |
36 |
| 2025-Q4 | Increased | 2.8M | +30.6% | $43.7M | 0.2% | $15.90 | 44 |
| 2025-Q3 | Unchanged | 2.1M | 0.0% | $25.4M | 0.1% | $15.16 | 0 |
| 2025-Q2 | Unchanged | 2.1M | 0.0% | $16M | 0.1% | $7.50 | 0 |
| 2025-Q1 | Increased | 2.1M | +0.7% | $11.7M | 0.1% | $5.71 | 28 |
| 2024-Q4 | Unchanged | 2.1M | 0.0% | $12.1M | 0.1% | $5.85 | 0 |
| 2024-Q3 | Increased | 2.1M | +0.6% | $21.8M | 0.1% | $10.05 | 34 |
| 2024-Q2 | Unchanged | 2.1M | 0.0% | $27.2M | 0.1% | $12.97 | 0 |